Genfit S.A. (GNFT)
Official siteBIOTECHNOLOGY
Last updated: Jun 24, 2026 at 5:00 PM ET
Genfit S.A. (GNFT) Financials: Revenue, Profit and Cash Flow
Genfit reported revenue of EUR 67.00M for the fiscal year ended Dec 31, 2024, up 134.6% from the year before. That year, net income was EUR 1.51M with a net margin of 2.2%, operating cash flow was EUR 15.20M and free cash flow was EUR 14.22M. The quarter ended Jun 30, 2025 had revenue of EUR 35.53M and net income of EUR -9.96M.
Revenue and Margins
The operating margin was 4.9% in the fiscal year ended Dec 2024. Over the 9 years to Dec 2024, revenue grew from EUR 527.00K, a compound annual rate of 71.3%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2024 | 67.00M | +134.6% | 99.6% | 4.9% | 2.2% |
| Dec 2023 | 28.57M | +41.4% | 98.8% | -93.1% | -101.2% |
| Dec 2022 | 20.20M | -74.8% | 98.8% | -135.1% | -117.5% |
| Dec 2021 | 80.07M | +10366.5% | 99.8% | 39.7% | 84.0% |
| Dec 2020 | 765.00K | -97.5% | 73.6% | -10836.2% | -13231.5% |
| Dec 2019 | 30.84M | +44594.2% | 99.4% | -187.5% | -211.2% |
| Dec 2018 | 69.00K | -41.5% | -2587.0% | -100701.4% | -115247.8% |
| Dec 2017 | 118.00K | -58.5% | -1789.0% | -48046.6% | -49664.4% |
| Dec 2016 | 284.00K | -46.1% | -598.9% | -12027.5% | -11854.6% |
| Dec 2015 | 527.00K | N/A | -266.4% | -3354.1% | -3251.4% |
Income Statement
In the fiscal year ended Dec 2024, net income turned positive after a loss the year before. In the quarter ended Jun 2025, the company posted a net loss after a profit in the same quarter a year earlier.
Annual
| Line item | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 67.00M | 28.57M | 20.20M | 80.07M | 765.00K | 30.84M | 69.00K | 118.00K | 284.00K | 527.00K |
| Cost of revenue | 300.00K | 341.00K | 248.00K | 161.00K | 202.00K | 177.00K | 1.85M | 2.23M | 1.99M | 1.93M |
| Gross profit | 66.70M | 28.22M | 19.95M | 79.91M | 563.00K | 30.66M | -1.78M | -2.11M | -1.70M | -1.40M |
| Research and development | 47.21M | 46.71M | 35.82M | 35.17M | 59.10M | 66.17M | 47.66M | 35.09M | 19.19M | 5.39M |
| Operating income | 3.28M | -26.58M | -27.29M | 31.82M | -82.90M | -57.83M | -69.48M | -56.70M | -34.16M | -17.68M |
| Net income | 1.51M | -28.89M | -23.72M | 67.26M | -101.22M | -65.14M | -79.52M | -58.60M | -33.67M | -17.14M |
| EBITDA | 8.35M | -22.24M | -25.80M | 34.91M | -73.03M | -49.03M | -68.08M | -55.76M | -33.53M | -17.35M |
Quarterly
| Line item | Jun 2025 | Mar 2025 | Dec 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 35.53M | 5.90M | 5.90M | 61.10M | 14.27M | 14.27M | 2.82M | 11.48M | 7.56M | 6.09M | 5.31M | 8.79M |
| Gross profit | 35.53M | 6.46M | 6.46M | 61.10M | 19.37M | 19.37M | 2.82M | 15.11M | 7.56M | 6.09M | 5.31M | 12.14M |
| Operating income | 76.00K | -27.94M | -27.94M | 31.22M | -2.84M | -2.84M | 2.82M | -23.74M | -9.65M | -15.73M | 5.31M | -17.50M |
| Net income | -9.96M | -28.80M | -28.80M | 30.31M | -8.04M | -8.04M | -4.02M | -20.85M | -10.43M | -13.50M | -6.66M | -10.40M |
Balance Sheet
As of Dec 2024, cash and equivalents exceeded total debt of EUR 57.07M by 24.71M.
Annual
| Line item | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 151.42M | 173.87M | 215.54M | 281.72M | 198.61M | 309.85M | 229.48M | 293.18M | 166.21M | 69.26M |
| Current assets | 92.77M | 113.11M | 158.46M | 268.10M | 184.72M | 290.75M | 218.12M | 283.57M | 162.00M | 66.75M |
| Cash and equivalents | 81.79M | 77.79M | 136.00M | 258.76M | 171.03M | 276.75M | 207.24M | 273.82M | 152.28M | 60.11M |
| Total liabilities | 82.20M | 105.92M | 121.01M | 162.62M | 214.78M | 225.79M | 208.54M | 188.95M | 23.42M | 13.84M |
| Short-term debt | 55.44M | 6.85M | 4.05M | 1.10M | 2.26M | 2.42M | 2.64M | 2.74M | 1.17M | 1.22M |
| Long-term debt | 1.64M | 57.45M | 64.67M | 66.07M | 173.30M | 168.91M | 165.05M | 160.05M | 4.70M | 4.48M |
| Shareholder equity | 69.22M | 67.95M | 94.53M | 119.10M | -16.16M | 84.06M | 20.94M | 104.23M | 142.80M | 55.42M |
Quarterly
| Line item | Jun 2025 | Mar 2025 | Dec 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 216.68M | 151.42M | 151.42M | 194.78M | 173.87M | 173.87M | 173.87M | 193.91M | 193.91M | 215.54M | N/A | 237.05M |
| Total liabilities | 164.21M | 82.20M | 82.20M | 97.41M | 105.92M | 105.92M | 105.92M | 119.39M | 119.39M | 121.01M | N/A | 127.88M |
| Cash and equivalents | 107.51M | 81.79M | 81.79M | 61.65M | 77.79M | 77.79M | 77.79M | 111.83M | 111.83M | 136.00M | N/A | 209.12M |
| Shareholder equity | 52.47M | 69.22M | 69.22M | 97.36M | 67.95M | 67.95M | 67.95M | 74.52M | 74.52M | 94.53M | N/A | 109.17M |
Cash Flow
In the fiscal year ended Dec 2024, free cash flow was 93.6% of operating cash flow. The company paid no dividends and bought back no shares.
Annual
| Line item | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 15.20M | -55.43M | -72.64M | 99.92M | -96.37M | -47.68M | -56.08M | -49.86M | -27.23M | -14.87M |
| Capital expenditures | 979.00K | 2.49M | 2 | 537.00K | 900.00K | 2.03M | 2.94M | 2.80M | 2.04M | 790.00K |
| Free cash flow | 14.22M | -57.92M | -72.64M | 99.38M | -97.27M | -49.71M | -59.02M | -52.66M | -29.26M | -15.66M |
| Investing cash flow | -1.04M | 2.23M | -46.27M | -3.38M | -966.00K | 327.00K | -3.99M | -2.95M | -2.09M | 3.50M |
| Financing cash flow | -10.57M | -5.10M | -3.79M | -8.92M | -8.26M | 116.86M | -6.51M | 174.35M | 121.48M | -520.00K |
Quarterly
| Line item | Jun 2025 | Mar 2025 | Dec 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -30.10M | 26.93M | 26.93M | -11.19M | -30.36M | -30.36M | -15.18M | -25.84M | -12.54M | -26.14M |
| Capital expenditures | 1.05M | 242.00K | 242.00K | 737.00K | 414.00K | 414.00K | 207.00K | 2.00M | 0 | 1 |
| Free cash flow | -31.16M | 26.68M | 26.68M | -11.92M | -30.77M | -30.77M | -15.38M | -27.84M | -12.54M | -26.14M |
Frequently Asked Questions About GNFT
What is Genfit's annual revenue?
Genfit reported revenue of EUR 67.00M for the fiscal year ended Dec 31, 2024.
How fast is Genfit's revenue growing?
Revenue was up 134.6% for the fiscal year ended Dec 31, 2024 compared with the year before. The compound annual revenue growth rate over 3 years was -5.8%.
Is Genfit profitable?
Yes. Genfit reported net income of EUR 1.51M for the fiscal year ended Dec 31, 2024, with a net margin of 2.2%.
How much free cash flow does GNFT generate?
For the fiscal year ended Dec 31, 2024, operating cash flow of EUR 15.20M minus capital expenditures of EUR 979.00K produced free cash flow of EUR 14.22M.
How much debt does Genfit have?
The balance sheet dated Dec 31, 2024 reported long-term debt of EUR 1.64M, short-term debt of EUR 55.44M and cash and equivalents of EUR 81.79M.
GNFT pages: Overview, Financials